Global Infant Medicine Syringes Market 2026 – 2035

As per the infant medicine syringes market analysis conducted by the CMI team, the infant medicine syringes market is expected to record a CAGR of 5.89% from 2026 to 2035. In 2026, the market size was USD 662.06 Million. By 2035, the valuation is anticipated to reach USD 1108.13 Million. The market is expanding due to growing focus on precise pediatric dosing, rising awareness of safe drug administration practices, and growing incidences of childhood ailments that need liquid medications.

This demand is supported further by oral dosing syringes’ widespread use in NCUs (neonatal intensive care units), hospitals, and home care settings, apart from continual enhancements in material safety (like BPA-free plastics), syringe design, and easy use. Pediatric healthcare infrastructure is thus focusing on infant safety.

Market Highlights

• North America dominated the infant medicine syringes market in 2025 with 49.34% of the overall share.

• The Asia Pacific is expected to witness the fastest CAGR of 4.5% in the infant medicine syringes market during the forecast period.

• By type, oral syringes held around 62.37% of the market share by 2025.

• By type, nasal syringes are expected to witness the fastest CAGR of 4.34% between 2026 and 2035.

• Through material, plastic syringes dominated in 2025 with 59.23% of the overall market share.

• By material, glass syringes are expected to witness the fastest CAGR of 4.97% between 2026 and 2035.

• By end-user, hospitals dominated in 2025 with 47.64% of the overall market share.

• By end-user, home care settings are expected to witness the fastest CAGR of 5.34% between 2026 and 2035.

Significant Growth Factors

• Awareness of Precise Pediatric Dosing

Caregivers and healthcare professionals are increasingly favoring oral dosing syringes over conventional measuring spoons or cups owing to their accuracy, safety, and ease of use, particularly in home care and neonatal settings. The increasing incidences of infant illnesses, along with the expansion of treatment and immunization programs, is bolstering the demand for dependable drug delivery tools. Moreover, advancements like anti-choking features, clear measurement markings, and medical materials free of BPA are improving safety and usability.

• Continual Innovation in Syringe Materials and Design

The manufacturers are emphasizing features like ergonomic designs, measurement markings that are easier to read, anti-backflow mechanisms, and medical-grade plastics free of BPA for ensuring both caregiver confidence and infant safety. Also, expanding pediatric healthcare infrastructure, particularly in the emerging economies, is driving novel growth opportunities. The government initiatives that are extending support to child health programs are contributing to the market further. The ongoing trend of OTC (over-the-counter) pediatric medications and home-based infant care is reinforcing demand for reliable and user-friendly dosing solutions, thereby positioning the infant medicine syringes as a necessary tool in modern pediatric healthcare parlance.

What are the Major Advancements Changing the Infant Medicine Syringes Market Today?

• Development of Safety-enhanced and Precision-Engineered Syringe Designs

Modern-day infant syringes are incorporating features like easy-to-read, ultra-clear measurement markings, spill-proof or anti-backflow mechanisms, and color-coded dosing indicators that ensure controlled and precise delivery of medications. Such innovations are especially crucial in pediatric and neonatal care, where even minor dosage errors are likely to have serious consequences. Plus, advancements like silicone-tipped or soft-tip syringes are enhancing comfort and lessening the risk of getting injured while administering medications through them. Ergonomic designs with enhanced plunger control and grip are also improving the usability, particularly in home care settings, thereby raising overall reliability and adoption of such devices.

• Use of Safe, Advanced, and Sustainable Materials

The manufacturers are visibly shifting to phthalate-free, BPA-free, and medical-grade plastics for ensuring compliance with strict safety standards and also for addressing growing concerns regarding chemical exposure in the infant products. Plus, innovations with respect to single-use sterile packaging and antimicrobial coatings are enhancing hygiene and lessening risk of contamination, which is crucial in both – home and hospital environments. Certain emerging developments are also inclusive of smart or digital dosing aids, wherein the syringes are paired with measurement-assist devices or apps for guiding the caregivers on precise timings and dosage. Moreover, sustainability is turning out to be one of the key focus areas, with efforts being taken for reducing plastic waste and developing recyclable materials.

• Impact of AI on Infant Medicine Syringes Market

AI has started influencing infant medicine syringes market by improving dosing precision, product development processes, and caregiver guidance. The AI-powered applications, along with smart healthcare platforms, are capable of assisting healthcare providers and parents in determining accurate medication dosages on the basis of an infant’s weight, age, and medical condition, thereby lessening risk of dosing errors. Plus, integrating AI with digital tools like mobile apps or connected dosing devices facilitates usage tracking, reminders, and real-time guidance, thereby enhancing safety in the home care settings. Coming to the production side, AI is getting used for optimizing design, predicting material performance, and improving quality control. As such, it results in more user-friendly and reliable syringe products.

Category Wise insights

By Type

Why are oral syringes dominating the infant medicine syringes market?

Oral syringes are dominating the infant medicine syringes market as they make provisions for precise dosing, enhanced safety, and ease of administration in comparison with conventional methods such as cups or spoons. Infants need small-volume, precise medication doses. Oral syringes let caregivers measure as well as deliver exact quantities directly into the infant’s mouth, thereby visibly reducing risk of overdosing or underdosing. Their design also minimizes choking hazards and spillage, thereby rendering them safer for usage in both – home and clinical settings. Besides, oral syringes are broadly recommended by the healthcare personnel. Features like ergonomic grips, clear measurement markings, and rounded or soft trips improve comfort and usability, thereby reinforcing the position as an ideal choice with respect to infant medication delivery.

By Material

How are plastic syringes leading the infant medicine syringes market?

Plastic syringes are leading the infant medicine syringes market owing to their safety, cost-effectiveness, and widespread availability, thereby rendering them conducive to both – home use and healthcare facilities. They are usually made from medical-grade, BPA-free plastics ensuring safety for the infants while maintaining lightweight handling and durability. They are also easy to produce at a large scale, thereby reducing risk of infection and contamination, which is crucial in pediatric care. The transparency on their part allows for precise measurement markings and liquid medication’s clear visibility, thereby improving dosing accuracy.

By End-user

Why do hospitals dominate the infant medicine syringes market?

The hospitals dominate infant medicine syringes market as they are primary point-of-care for the infants and newborns, particularly in critical settings like NICUs (neonatal intensive care units), wherein accurate dosing and stern safety protocols are necessary. The healthcare professionals in hospitals heavily depend on oral syringes for precise as well as controlled drug administration, especially for medically vulnerable infants. The hospitals also align with strict regulatory and hygiene standards, thereby favouring use of single-use, sterile syringes for minimizing the risk of infection.

Report Scope

Regional Analysis

How big is North America’s infant medicine syringes market size?

North America’s infant medicine syringes market was worth USD 308.49 Million in 2025 and is expected to reach USD 544.93 Million by 2035 at a CAGR of 6.29% between 2025 and 2035.

Why did North America Dominate the Infant Medicine Syringes Market in 2025?

North America dominated the infant medicine syringes market in 2025 owing to it being home to well-established healthcare infrastructure, higher awareness of pediatric medication safety, and widespread adoption of accurate dosing tools in both – home care and clinical settings. The region does benefit from presence of the medical device producers, continued product innovation, and higher healthcare spending.

What is the Size of the U.S. Infant Medicine Syringes Market?

The market size of the U.S. infant medicine syringes was USD 213.57 Million in 2025 and expected to reach USD 341.49 Million in 2035, and witnessing a CAGR of 4.87% between 2026 and 2035.

U.S. Infant Medicine Syringes Market Trends

The U.S. infant medicine syringes market growing owing to integration of medical-grade, high class materials and enhanced syringe designs inclusive of clear measurement markings, better plunger control, ad BPA-free components, thereby improving usability and safety. Plus, demand is getting fueled by expanding pharmacy-dispensed dosing devices and home-based pediatric care, along with robust institutional demand from NICUs and hospitals wherein compliance and precision are critical.

Why is the Asia Pacific experiencing the fastest growth in the infant medicine syringes market?

The Asia Pacific is witnessing the fastest CAGR in infant medicine syringes market owing to its huge infant population, enhancing healthcare infrastructure, and growing awareness of pediatric medication safety across Indonesia, India, and China. Rising birth rates in various parts, along with expansion of access to clinics, hospitals, and neonatal care services are encouraging the demand for precise dosing tools such as oral syringes. The governments are also focusing on child immunization programs, healthcare, and maternal health. The market for the Asia Pacific is also witnessing shift toward OTC pediatric medications and home-based infant care.

China Infant Medicine Syringes Trends

With China continuing to strengthen the healthcare system, especially in semi-urban and urban regions, adoption of accurate medication delivery tools like oral syringes is rising across pharmacies, hospitals, and home care settings. The government-led enhanced access to pediatric care is encouraging usage of standardized dosing devices, thereby replacing conventional methods. Apart from ergonomic designs and BPA-free materials, expansion of e-Commerce platforms and retail pharmacies is providing greater accessibility to the caregivers.

Where does Europe stand with respect to infant medicine syringes market?

Europe holds a significant position in the infant medicine syringes market due to a well-developed healthcare sector, robust regulatory frameworks, and higher standards set for pediatric medication safety. The economies such as the U.K., Germany, and France are supporting market growth with home care settings, pharmacies, and hospitals consistently using oral dosing syringes for precise delivery of infant medications. In all, Europe continues to be a key market owing to its emphasis on safety standards, precision dosing, and stable healthcare funding, thereby ascertaining consistent adoption across pediatric care.

Germany Infant Medicine Syringes Market Trends

Germany's infant medicine syringe market witnesses an increased adoption of high-precision, clinically validated oral dosing syringes across NICUs and hospitals, wherein precise dosing for the low bodyweight infants is crucial. The market is also getting benefited from continuous improvements in the syringe design, inclusive of better sealing mechanisms, improved plunger control, and usage of medical-grade materials that are BPA-free. The region also boasts standardized clinical protocols and well-established hospital procurement systems, which are ascertaining consistent demand for sterile, high class, single-use syringes.

Where is the Middle East & Africa regarding the infant medicine syringe market?

The MEA infant medicine syringe market is at the developing stage as of now but is expected to expand in the near future due to rising awareness of pediatric medication safety. Economies like Saudi Arabia, the UAE, and South Africa are dominating as far as regional adoption is concerned, supported by rising investments in child and maternal healthcare programs, hospitals, and government initiatives aimed at improvement of infant health outcomes. Oral syringes are witnessing an increasing demand in both – home care and hospital settings as the healthcare providers focus on safe and precise medication delivery for the infants.

Brazil Infant Medicine Syringes Market Trends

Brazil's infant medicine syringe market is expected to witness steadiness during the forecast period due to expansion of pediatric healthcare services, robust public healthcare investments, and rising awareness of precise infant dosing. Systems like ANVISA are in place. Growing incidences of childhood ailments are lending support to higher demand for precise and safe oral dosing solutions in both home care and hospital settings. The pharmacy chains are also expanding, with a switch to BPA-free syringes.

Top players in the Infant Medicine Syringes Market and their Offerings

• Becton Dickinson and Company (BD)

• Cardinal Health

• Terumo Corporation

• Nipro Corporation

• B. Braun Melsungen AG

• Others

Key Developments

Infant medicine syringe market has experienced considerable changes in the last few years as the market players are trying to diversify their technological aspects and develop product portfolios using strategic approaches.

• BD and various other global manufacturers are upscaling production in numerous regions for ascertaining supply stability and reducing dependency-related risks while responding to the regulatory concerns around safety and quality standards in the production of syringes.

These strategic measures have enabled the companies to reinforce their competitive positions, increase the product line, boost their technological competencies, and also seize growth opportunities in the fast-growing infant medicine syringes market.

The Infant Medicine Syringes Market is segmented as follows:

By Type

• Oral Syringes

• Nasal Syringes

By Material

• Plastic

• Glass

End-user

• Hospitals

• Clinics

• Homecare Settings

Regional Coverage:

North America

• U.S.

• Canada

• Mexico

• Rest of North America 

Europe

• Germany

• France

• U.K.

• Russia

• Italy

• Spain

• Netherlands

• Rest of Europe

Asia Pacific

• China

• Japan

• India

• New Zealand

• Australia

• South Korea

• Taiwan

• Rest of Asia Pacific 

The Middle East & Africa

• Saudi Arabia

• UAE

• Egypt

• Kuwait

• South Africa

• Rest of the Middle East & Africa

Latin America

• Brazil

• Argentina

• Rest of Latin America